Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Casillo Group is an Italian private industrial group founded in 1958 that leads globally in the processing and distribution of durum wheat and ranks among Europe's largest soft wheat millers. Its core business spans agricultural commodities trading on a global scale; production of flours for pasta makers/bakeries/F&B clients/B2C channels; cereal storage/logistics; renewable energy initiatives using agri-byproducts ("circular economy"); real estate projects tied to its industrial base; and more recently food tech innovation through subsidiaries like "Casillo Next Gen Food" which extracts high-value ingredients from milling by-products such as germ fractions rich in protein/fiber/vitamins. The group operates at least 14 mills across Italy with significant investments into modernization, but it does not develop pharmaceuticals or biotech products nor conduct clinical research—its activities are strictly within the food/agriculture sector rather than life science/biotech/pharma/healthcare fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Casillo Group.